GeneFerm Biotechnology Co Ltd (1796) — Strategic Asset Allocation Index
GeneFerm Biotechnology Co Ltd (1796) has a Strategic Asset Allocation Index of 94.4% as of June 2023. Strategic assets (PP&E of NT$797.54 Million plus long-term investments of NT$-) total NT$797.54 Million, measured against net assets of NT$845.27 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check GeneFerm Biotechnology Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
GeneFerm Biotechnology Co Ltd Strategic Asset Allocation Index (2017–2022)
This chart shows how GeneFerm Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 94.4%, representing strategic assets of NT$797.54 Million against net assets of NT$845.27 Million TWD. See 1796 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for GeneFerm Biotechnology Co Ltd (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GeneFerm Biotechnology Co Ltd from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see GeneFerm Biotechnology Co Ltd (1796) market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 88.4% | NT$734.28 Million | NT$734.28 Million | NT$- | NT$830.77 Million | ▲ +20.1 pp |
| 2021 | 68.3% | NT$510.38 Million | NT$510.38 Million | NT$- | NT$747.66 Million | ▼ -38.1 pp |
| 2020 | 106.4% | NT$421.44 Million | NT$421.44 Million | NT$- | NT$396.19 Million | ▲ +65.9 pp |
| 2019 | 40.4% | NT$385.84 Million | NT$385.84 Million | NT$- | NT$954.50 Million | ▼ -23.4 pp |
| 2018 | 63.8% | NT$265.86 Million | NT$265.86 Million | NT$- | NT$416.51 Million | ▼ -20.4 pp |
| 2017 | 84.2% | NT$265.30 Million | NT$265.30 Million | NT$- | NT$314.95 Million | — |